Zymeworks Incis A Clinical Stage Biotechnology Company Based In Vancouvercanadawith Additional Offices In The U S Irelandthe Ukand Singaporefounded In 2003Zymeworks Focuses On Developing Innovative Biotherapeutics For Challenging Diseasesincluding Cancer And Autoimmune Disordersthe Company Is Publicly Traded On Nasdaq Under The Ticker Zyme And Employs Around 275 People Zymeworks Operates Two Main Platformsazymetrica Cwhich Engineers Bispecific Antibodies To Target Multiple Disease Pathwaysand Efecta Cwhich Enhances Immune Cell Function For Better Antibody Therapiesthe Company Has Developed Several Key Productsincluding Zanidatamaba Bispecific Antibody Approved In The U Sfor Her2 Positive Biliary Tract Cancerand Is Advancing Multiple Candidates In Clinical Trialszymeworks Collaborates With Major Biopharmaceutical Firms Like Beigene And Jazz Pharmaceuticals To Expand Its Therapeutic Reach And Validate Its Innovative Platforms
No conferences found for this company.
| Company Name | Zymeworks Biopharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
